Sep 28, 2022 / 09:00AM GMT
Cheryl-Jane Kujenga - Ascendis Health Limited - CFO, Interim CEO & Executive Director
Good morning, everyone, and welcome to our results presentation for the year ended 30 June 2022. I will be taking you through the results of our operations and performance for the financial year, and Carl will take you through our plans to accelerate the turnaround for the group.
It has been an eventful but constructive year for Ascendis. The first half of the year saw us complete the group recapitalization, where the ownership of our European assets, Remedica and Sun Wave, was transferred to LetterOne and Blantyre.
This transaction together with the disposal of Animal Health and RCA saw us reduce our debt balance by ZAR 7.6 billion. Our AGM was held in December, bringing with it a change to the Board in heralding a more shareholder-driven approach to our strategy and the harnessing value in the operations of the group. The second half of the year saw the debt trade hands a few times, a process that we leveraged to enable us to renegotiate more favorable terms with each subsequent
Full Year 2022 Ascendis Health Ltd Earnings Call Transcript
Sep 28, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers